Lek Takeover: Novartis Raises Bid
Ljubljana, 19 October - Servipharm, a subsidiary of the Novartis company, published on Saturday its modified bid for the purchase of all the shares of the Ljubljana-based drug maker Lek, raising its offer to SIT 105,000 (EUR 459) for one Lek share. Thus, the validity of the bid has also been extended until 4 November at noon.
The rest of this news item is available to subscribers.
The news item consists of 1.142 characters (without spaces) or 234 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.